Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 4, 1999, Pages 252-256

  Kunt, Thomas ^a   Forst, T ^b   Fruh B ^b   Flohr, T ^b   Schneider, S ^b   Harzer, O ^b   Pfutzner A ^b   Engelbach, M ^b   Lobig M ^b   Beyer, J ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NONE

Author keywords

Atherosclerosis; Monocyte binding; Normolipidemia; Type 1 diabetes

Indexed keywords

CYTOKINE; GLUCOSE; HEMOGLOBIN A1C; PROTEIN KINASE C;

ARTICLE; CELL INTERACTION; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMMUNOFLUORESCENCE TEST; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE ADHERENCE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032993826     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212108     Document Type: Article

References (23)

1. Bilato C, Crow MT: Atherosclerosis and the vascular biology of aging. Aging Milano 8: 221-234, 1996
2. Briones ER, Mao SJ, Palumbo PJ, O'Fallon WM, Chenoweth W, Kottke BA: Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics. Metabolism 33: 4-9, 1984
3. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46: 223-234, 1995
4. Carantoni M, Abbasi F, Chu L, Chen YD, Reaven GM, Tsao PS, Varasteh B, Cooke JP: Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM. Diabetes Care 20: 1462-1465, 1997
5. Cerami A, Vlassara H, Brownlee M: Glucose and aging. Sci Am 256: 90-96, 1987
6. De Caterina R, Gimbrone MA: Leukocyte-endothelial interactions and the pathogenesis of atherosclerosis. In: N-3 fatty acids: prevention and treatment in vascular disease. Kristensen SD, Schmidt EB, De Caterina R, Endres S. Bi&Gi, London: 9-24, 1995
7. Garcia MJ, Mc Namara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23: 105-111, 1974
8. Hogg N, Berlin C: Structure and function of adhesion receptors in leukocyte trafficking. Immunology today 16: 327-330, 1995
9. Hoogerbrugge N, Postema PT, Verkerk A, Jongkind JF, Jacobs ML: Hypertriglyceridemia enhances monocyte binding to endothelial cells in NIDDM. Diabetes Care 19: 1122-1125, 1996
10. Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Bennett PH: Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population: comparison of diabetics and non-diabetics. Arteriosclerosis 4: 462-471, 1984
11. Jaffé WA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins:identification by morphologic and immunologic criteria . J Clin Invest 52: 2745-2756, 1973
12. Kim JA, Berliner JA, Natarajan RD, Nadler JL: Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 43: 1103-1107, 1994
13. King GL, Brownlee M: The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25: 255-270, 1996
14. Kunt T, Forst T, Harzer O, Buchert G, Pfuetzner A, Löbig M, Engelbach M, Beyer J: The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules. Exp Clin Endocrinol Diabetes 106: 1998(a)
15. Kunt T, Forst T, Pfützner A, Harzer O, Zschäbitz A, Beyer J, Ways K, Stofft E: The impact of the (-isoform of protein kinase C (PKC() on the endothelial binding of monocytes. FASEB J 12 (4): A776, 1998 (b)
16. Kunt T, Zschäbitz A, Beyer J, Forst T, Engelbach M, Stofft E: Die leukozytär-endotheliale Interaktion unter dem Einfluß von "advanced glycation endproducts (AGE)" - eine elektronenoptische und molekularbiologische Untersuchung. Annals of Anatomy 176 (6): 279-280 (Suppl.) 1997
17. Lee TS, Saltsman KA, Ohashi H, King GL: Activation of protein kinase C by elevation of glucose: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86: 5141-5145, 1989
18. Manske CL: Coronary artery disease in diabetic patients with nephropathy. Am J Hypertens 6: 367S-374S, 1993
19. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96: 1395-1403, 1995
20. Springer TA: Adhesion receptors of the immune system. Nature 346: 425-434, 1990
21. Vlassara H: Advanced glycation end-products and atherosclerosis. Ann Med 28: 419-426, 1996
22. Vlassara H, Bucala R: Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors. Diabetes 45 Suppl 3: S65-6, 1996
23. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43: 1122-1129, 1994